Fig. 7From: Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of gliomaimmune microenvironment of DRLs prognostic model. (A). The box plot exhibiting the expression level of immune checkpoint genes between the high- and low-risk groups. (B). The single-sample gene set enrichment analysis (ssGSEA) displaying the extent of immune cell infiltrations in the high- and low-risk groups. (C). The ssGSEA analysis indicating the functions of immune cell subpopulations between the high- and low-risk groups. (D-F). The ESTIMATE score, immune score, and stromal score in the high- and low-risk groups. *p < 0.05, **p < 0.01, ***p < 0.001Back to article page